Login

Audentes Therapeutics, Inc. 4 SEC Filings

Filed On Filing
15 Jan 2020 Form 4: Soloway Thomas P, Executive Vice President, CFO

Disposed of 183,384 shares (Tender Offer) ($11M) · Disposed of 223,873 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Smith Julie, Director

Disposed of 53,200 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Schuetz Thomas J., Director

Disposed of 89,695 shares (Tender Offer) ($5.38M) · Disposed of 67,891 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Patterson Matthew R, Director

Disposed of 433,272 shares (Tender Offer) ($26M) · Disposed of 734,353 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Mosbrooker Eric, SVP, Chief Commercial Officer

Disposed of 26,919 shares (Tender Offer) ($1.62M) · Disposed of 87,750 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Morrison Scott W, Director

Disposed of 77,835 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Meltz Mark A, SVP, General Counsel

Disposed of 32,705 shares (Tender Offer) ($1.96M) · Disposed of 104,000 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Lange Louis G, Director

Disposed of 315,375 shares (Tender Offer) ($18.9M) · Disposed of 53,200 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Jarrett Jennifer, Director

Disposed of 53,200 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Holles Natalie C., President and COO

Disposed of 104,439 shares (Tender Offer) ($6.27M) · Disposed of 320,348 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Goldberg Mark Alan, Director

Disposed of 1,500 shares (Tender Offer) ($90K) · Disposed of 48,700 Stock Option (Right to Buy) (Disposition to Issuer)

15 Jan 2020 Form 4: Conner Edward R., SVP, Chief Medical Officer

Disposed of 24,584 shares (Tender Offer) ($1.48M) · Disposed of 90,000 Stock Option (Right to Buy) (Disposition to Issuer)

10 Jan 2020 Form 4: Soloway Thomas P, Executive Vice President, CFO

Received 150,888 shares by exercise or conversion ($495K)

10 Jan 2020 Form 4: Patterson Matthew R, Director

Gave 12,500 shares as a gift · Received 162,538 shares by exercise or conversion ($504K)

27 Dec 2019 Form 4: Lange Louis G, Director

Sold 11,000 shares ($656K)

16 Dec 2019 Form 4: Soloway Thomas P, Executive Vice President, CFO

Gave up 30,139 shares to cover exercise price or tax ($1.79M) · Received 41,321 shares by exercise or conversion ($114K)

16 Dec 2019 Form 4: Mosbrooker Eric, SVP, Chief Commercial Officer

Gave up 4,881 shares to cover exercise price or tax ($290K)

16 Dec 2019 Form 4: Meltz Mark A, SVP, General Counsel

Gave up 4,628 shares to cover exercise price or tax ($275K)

16 Dec 2019 Form 4: Holles Natalie C., President and COO

Gave up 97,609 shares to cover exercise price or tax ($5.8M) · Received 140,453 shares by exercise or conversion ($1.68M) · Received 6,891 shares by exercise or conversion ($189K)

16 Dec 2019 Form 4: Conner Edward R., SVP, Chief Medical Officer

Gave up 5,416 shares to cover exercise price or tax ($322K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support